Ivy Review: Weight Management Access, Evidence Gaps, and Risks

Ivy Rx is a telehealth-based platform that provides various formulations that are primarily focused on weight management, metabolic health, and longevity-oriented support.

The company operates through a remote care model that combines online health intake and clinician review without in-person visits.

The platform’s core offerings are said to provide additional support in weight management, alongside a range of adjunct options commonly associated with metabolic and cellular support.

They are positioned for use in addressing factors such as appetite regulation, metabolic efficiency, fatigue, recovery, and age-associated functional changes, subject to provider evaluation and prescribing discretion.

This review examines Ivy’s working process, categories, and its personalized model within the broader telehealth services landscape. It also considers practical strengths and limitations related to access, scope of plans, and regulatory context, alongside real user-reported experiences to provide a complete understanding of how the platform performs in everyday use.

About Ivy

Ivy Rx claims to provide clinician-guided prescription options and products focused on weight management and longevity support. It operates without insurance requirements and delivers support through online assessments, licensed provider review, and home delivery of prescribed products. Its stated model prioritizes streamlined access and individualized plan selection based on your reported health history and clinical eligibility.

The care process follows a defined three-step structure. You are required to complete an online intake questionnaire covering medical history, lifestyle factors, and health goals. This information is reviewed by a licensed medical provider, who determines whether the plan is clinically appropriate.

If approved, medications are then shipped directly to you, typically within a short delivery window. You also retain access to follow-up support and can communicate with providers to address questions or make adjustments over time.

The platform claims to source compounded medications from partner pharmacies that report compliance with applicable 503B outsourcing and USP <797> sterile compounding standards.

Ivy’s offerings are concentrated in several categories. Weight management options include compounded GLP-1, lower-dose GLP-1 formulations, metformin, MIC + B12, and related supplements intended to support appetite control and metabolic function.

Longevity- and aging-related offerings include NAD+, sermorelin, vitamin B12, and glutathione, which are commonly discussed in the context of cellular energy, recovery, and age-associated functional changes.

The platform also offers non-prescription supplements, such as peptide-based and metabolic-support formulations, intended for routine wellness use alongside prescription options.

Ivy Rx states that its clinical oversight is informed by a medical advisory board composed of physicians with diverse clinical and leadership backgrounds. The board is described as providing strategic and clinical guidance rather than direct care within the platform’s day-to-day operations.

Members mentioned by the company include Silvia Mosher, a board-certified hematologist with more than 25 years of experience, Rocio Reategui, a board-certified oncologist serving as Medical Director, and Katy Ordoñez, a physician with over two decades of clinical experience spanning pediatric oncology, palliative care, academic instruction, and nonprofit healthcare advocacy.

The advisory board’s role, as presented, is focused on informing clinical standards, plans, frameworks, and organizational direction, rather than overseeing individual prescribing decisions or ongoing patient monitoring.

Ivy claims to work through a telehealth-enabled platform combining prescription formulas, compounded options, and additional products within a centralized digital workflow. Its model emphasizes access, speed, and individualized support decisions, positioning the service as an alternative pathway for seeking clinician-managed weight management and longevity-oriented support outside of traditional in-person settings.

Ivy Rx Services

1. Weight Management

   Ivy Rx offers a telehealth-based weight management program that provides access to provider-evaluated medications, including compounded GLP-1, selected based on your health history, goals, and clinical eligibility. Care is delivered fully online without insurance requirements, with plan decisions made by licensed medical professionals.

   The process begins with a free online assessment that gathers information about your medical background, lifestyle, and weight-related goals. That information is reviewed by a licensed provider, who determines whether medication is appropriate and which option may be suitable. If approved, medication is prescribed and shipped discreetly to your address.

   Compounded GLP-1 offered through the program is formulated with active ingredients such as semaglutide, which belongs to a class of medications which are called glucagon-like peptide-1 receptor agonists.

   GLP-1 receptor agonists may function by mimicking a naturally occurring hormone involved in appetite regulation, gastric emptying, and insulin signaling. By helping activate the GLP-1 receptors in the brain and gastrointestinal system, these formulations may help increase feelings of fullness, reduce appetite, and support lower caloric intake over time.

   Pricing reflects the specific plan selected. Compounded GLP-1 is available for around $175 per month, with a lower-dose compounded GLP-1 microdose option available at $155 per month.

   Additional options include compounded MIC plus B12, which is commonly used to support metabolic processes. The platform also provides access to a non-prescription GLP-1 Boost formulation.

   Ongoing access to medical support allows you to communicate with your guidance team about side effects, dose adjustments, and progress. Subscriptions can be managed or canceled according to Ivy RX’s policies.

2. Longevity Care

   Ivy Rx offers an anti-aging program that may support energy levels, cellular function, and vitality as part of a personalized plan.

   The platform states that you are required to follow a free online assessment that collects information about lifestyle factors, medical background, and areas of concern related to energy, recovery, and aging.

   A licensed provider reviews this information to determine whether the plan is appropriate and which option may align with your needs. If approved, medication is prescribed and delivered discreetly.

   Anti-aging options include NAD+, Sermorelin, and B12. NAD+ is intended to support cellular energy production by replenishing nicotinamide adenine dinucleotide, a coenzyme involved in mitochondrial function and metabolic processes that naturally decline with age.

   Sermorelin peptide stimulates the pituitary gland to signal your body’s own production of growth hormone, which may support recovery, body composition, and sleep quality over time. B12 formulations might support red blood cell formation, nervous system function, and energy metabolism.

Advantages Of Ivy

1. Physician-Led Review Workflow

   Ivy positions its care model around structured licensed medical oversight, emphasizing clinician judgment as a core determinant of plan decisions rather than relying primarily on automated decision logic.

   The brand frames physician involvement as an embedded component of its telehealth workflow designed to ensure medical appropriateness before any prescription is issued.

   According to Ivy, you begin care by completing a detailed online intake questionnaire covering medical history, symptoms, and objectives. This information is then reviewed by US licensed board certified physicians or nurse practitioners as a required step prior to prescription consideration. The platform states that this clinician review typically occurs within 24 hours and that prescriptions are authorized only when providers determine the plan is medically appropriate. Live video consultations are not required in all cases, but may be initiated when clinically indicated.

   The company further claims to operate under a formal medical advisory structure composed of licensed healthcare professionals with experience spanning family medicine, metabolic health, oncology, neurology, and personalized wellness planning. Ivy describes all affiliated providers as US licensed and board certified, reinforcing its positioning as a clinician guided platform rather than a protocol driven or automated prescribing service.

2. Centralized Care Coordination

   Ivy RX presents its care delivery model as being built on a cohesive digital infrastructure that consolidates clinical oversight, patient communication, prescription management, and fulfillment operations.

   Rather than dispersing these functions across multiple external systems, the brand states that its platform is designed to manage the full care journey within a single integrated environment, supporting continuity, efficiency, and oversight.

   According to Ivy, the user portal serves as the primary coordination hub for ongoing care. You can communicate directly with your assigned clinician through secure in platform messaging, enabling plan-related questions, follow up discussions, and guidance without relying on third party messaging tools or scheduling separate appointments.

   Ivy positions this structure as a way to preserve continuity by ensuring that all communication remains connected to documented intake information, clinical reviews, and active plans. It further states that prescription processing and fulfillment are managed through the same centralized system. After a licensed provider reviews and approves a plan recommendation, the prescription is transmitted directly to Ivy’s partner pharmacies for compounding and shipment to the patient. This workflow is framed as reducing administrative friction by removing the need for patients to coordinate independently between providers, pharmacies, and delivery services.

Potential Limitation

1. Fewer Optional Add-Ons

   Ivy RX follows a service model that prioritizes streamlined prescription access for GLP-1-based weight management NAD plus protocols and peptide plans such as Sermorelin. Care delivery is centered on clinician review supported by a digital patient portal and foundational educational resources. While this structure emphasizes efficiency and accessibility, it offers a more limited range of optional human led support services compared with broader telehealth platforms.

   From a clinical support standpoint, Ivy does not prominently offer elective add-ons such as dedicated lifestyle coaching teams, advanced metabolic or hormonal testing bundles, personalized nutrition planning by registered dietitians, wearable device integration, or tiered monitoring programs. Instead, the platform focuses on core medication delivery paired with basic educational guidance rather than comprehensive lifestyle or performance optimization services.

   The Ivy RX app provides a set of digital self service tools designed to support day to day adherence and engagement. These include medication and supplement tracking, goal monitoring AI driven motivational coaching, and general dietary guidance, such as macronutrient targets, recipes, grocery lists, and dietary restrictions, along with access to a supplements category. While functional, these tools are positioned as adjuncts rather than substitutes for ongoing human-led care programs.

Alternatives To Ivy Rx

1. Mochi Health

   Mochi Health and Ivy RX both operate in the GLP-1 and metabolic health space, but they diverge sharply in purpose, structure, and product emphasis.

   The platform Mochi Health is designed as a longitudinal medical clinic focused primarily on weight management, while Ivy RX is structured as a direct-to-consumer medication and wellness option that prioritizes rapid access to plans for weight management, energy, and longevity.

   Mochi Health’s pricing and care model is anchored in a recurring membership. The standard membership is around $79 per month, and includes unlimited access to a board-certified physician and a registered dietitian, nutrition and lifestyle coaching, ongoing monitoring, dose adjustments, and 24/7 customer support.

   Weight-management medications are more focuses in the membership, with compounded semaglutide priced at around $99 per month and compounded tirzepatide at around $199 per month.

   Ivy Rx, meanwhile, does not rely on a bundled membership model. Instead, it provides access to individual compounded options with per-product pricing and free online evaluations. Compounded GLP-1 options are listed starting at $175 per month for four doses, while a microdose GLP-1 option starts at $155 per month.

   Ivy RX also offers non-GLP-1 weight and metabolism products, such as MIC+B12 at around $179, marketed for fat metabolism, liver support, energy, and mood. Products such as GLP-1 Boost are available separately starting at $72 per month. Each product is positioned as a standalone purchase rather than part of a comprehensive care plan.

   The role of compounded formulations highlights a fundamental philosophical difference. Mochi presents compounded semaglutide and tirzepatide and integrates them into a broader medical, nutritional, and behavioral framework.

   Ivy RX places compounded options at the center of its value proposition, extending far beyond GLP-1s into longevity and performance-oriented formulas. These include NAD+ starting at $199, NAD+ nasal spray from $179, glutathione injections from $179, methylcobalamin (B12) at $179, and peptides and hormone-related compounds such as sermorelin. Ivy RX frames these products around cellular energy, cognitive focus, detoxification, and healthy aging.

   Mochi emphasizes continuity, with unlimited follow-up access to clinicians and dietitians, structured coaching, and long-term engagement. Ivy RX emphasizes speed and convenience with a short intake quiz, provider review, and medication delivery, without embedded nutrition counseling or required ongoing follow-up.

   Ivy highlights quality assurance as its primary trust mechanism, citing preparation in state-licensed pharmacies, USP <797> sterility standards, potency testing within ±10%, endotoxin screening, and pH balancing.

   The breadth of services also reinforces these differences. Mochi expands horizontally into traditional telehealth categories such as skincare, hair growth, hormonal care, mental health, and symptom management, all integrated into the same membership-based clinical structure.

   Ivy Rx expands vertically into longevity, wellness, and optimization products, positioning at-home formulations as substitutes for in-clinic IV plans that can cost $750 or more per visit, and emphasizing autonomy, discretion, and insurance-free access.

   Mochi Health is optimized for a structured, ongoing medical weight management with predictable monthly costs, integrated dietitian support, and documented retention and outcome metrics. Ivy RX is optimized for fast, flexible access to compounded options for weight management, energy, and longevity, with transparent per-product pricing and minimal program obligations.

2. Fridays

   Fridays positions itself as a comprehensive, fully online metabolic health platform oriented around long-term outcomes. Its model is built as a guided fitness journey that integrates pharmacologic options with lifestyle modification, behavioral support, and longitudinal clinical oversight.

   Fridays frames weight management, metabolic health, longevity, and hormone optimization as interdependent domains requiring personalization and continuity of care.

   The platform operates without requiring insurance participation but offers an insurance concierge service to help users maximize coverage where applicable, and it supports FSA and HSA payments. This structure highlights that Fridays maintains a consumer-first experience while selectively interfacing with traditional healthcare reimbursement systems.

   You can begin with Fridays with a short online medical intake designed to collect health history, goals, and baseline data. This intake does not establish a doctor–patient relationship. Instead, it is reviewed by U.S.-licensed clinicians operating through OpenLoop Health and other affiliated provider networks. These clinicians retain full discretion to approve, modify, or deny the process based on clinical appropriateness. When the plan is approved, prescriptions are fulfilled by certified U.S. partner pharmacies.

   Fridays’ weight management program is structured around GLP-1 delivered through multiple parallel pathways. Its primary options include a compounded GLP-1 formulation containing semaglutide, a compounded GLP-1/GIP liposomal liquid formulation containing tirzepatide, and a compounded GLP-1 liposomal liquid formulation containing semaglutide. In addition to compounded options, Fridays facilitates access to branded GLP-1 as well, specifically Zepbound and Ozempic.

   A distinctive extension of Fridays’ GLP-1 strategy is its microdosing program, which reframes GLP-1 and GLP-1/GIP as a lower-dose, functionally targeted intervention rather than a maximal-weight-management protocol. These offerings include compounded tirzepatide-based formulations branded as Microdose Core, Energy + Mind, and Muscle + Energy. These formulations are available in injectable and oral formats and are marketed for appetite control, cognitive clarity, mood balance, metabolic signaling, and energy enhancement rather than aggressive weight reduction. As with all other formulations on the platform, these microdosing programs are issued only after clinician review and include explicit regulatory disclosures.

   Medication use on Fridays is intentionally positioned as one component of a broader lifestyle and behavioral framework. Weight-management programs are bundled with access to registered dietitians, mental health coaching, structured workouts, and peer support groups.

   In addition to individualized nutrition support, Fridays offers weekly group coaching sessions that address nutrition, mindset, and movement. These sessions are positioned as educational and motivational resources rather than interventions and are intended to reinforce adherence and behavior change over time.

   Physical activity support is provided through access to the SESH Fitness App, which includes guided workouts and program-related journey resources, rather than live, instructor-led workouts embedded directly into the Fridays platform.

   Fridays include laboratory testing through Quest Diagnostics as part of its program structure, along with prior authorization assistance for branded medications when applicable and acceptance of HSA and FSA payments.

   Beyond weight management, Fridays also focuses on longevity and anti-aging, framed around metabolic resilience, cellular repair, and sustained energy. Core offerings include NAD+ delivered as formulations, liposomal liquids, and nasal sprays, marketed for energy support, cognitive focus, and cellular health. Fridays also offers sermorelin as a prescription peptide associated with growth hormone stimulation, along with B12-MIC aimed at metabolic and energy support.

   Fridays also extend into the testosterone replacement category through a dedicated TRT program framed around improvements in energy, libido, cognitive sharpness, mood stability, and physical strength. All programs are managed through the Fridays digital portal, which functions as a centralized dashboard for dose tracking, provider communication, progress monitoring, and access to coaching and support resources, reinforcing Fridays’ positioning as a longitudinal fitness partner.

   In contrast, Ivy RX presents a more streamlined, medication-first interpretation of telehealth, emphasizing speed, simplicity, and user autonomy. It positions itself as a direct-to-consumer platform focused on clinician-guided access to prescription formulations for weight management, longevity, and wellness without insurance involvement. Its care journey begins with a short online intake quiz, after which a licensed medical professional evaluates medical appropriateness before issuing any prescription.

   Weight management at Ivy RX is centered almost entirely on injectable compounded GLP-1. Offerings include compounded semaglutide, compounded tirzepatide, and GLP-1 microdose programs using these same active ingredients at lower doses. The compounds are prepared by state-licensed partner pharmacies and prescribed only after online evaluation by licensed physicians.

   Ivy RX’s longevity and wellness offerings emphasize compounded options associated with performance, recovery, and vitality. Core offerings include compounded NAD+, glutathione for antioxidant support, sermorelin for growth hormone stimulation, B12, and MIC+B12 for energy and metabolic support.

   Ivy RX further expands into peptide-based products such as BPC-157 and gut peptide complexes, along with products including methylene blue. Across all compounded options, Ivy RX emphasizes quality assurance over FDA approval, highlighting sterility testing under USP <797> standards. The platform presents itself as a fast, compounded-medication platform optimized for access and simplicity, whereas Fridays highlights a broader, programmatic, and longitudinal metabolic health ecosystem.

How Did We Evaluate?

1. Brand Reputation

   While evaluating the brand’s reputation, we have reviewed publicly available records from the Better Business Bureau. The BBB profile has shown that Ivy Rx, PLLC, is not accredited and has held a C rating.

   The BBB has reported some complaints filed in the past years, all of which have been closed within the last few months. A significant portion of these complaints has involved subscription billing and cancellation issues, including customers reporting charges after cancellation confirmations and delayed refunds.

   Several complaints have also described customers paying for multi-month or annual plans upfront and experiencing difficulty obtaining refunds when services were delayed or discontinued.

   Operational and fulfillment issues have appeared repeatedly in the complaint record. Customers have reported delayed shipments, medication delivered to incorrect addresses or states, refrigeration problems, pharmacy changes mid-plan, and inconsistent or conflicting dosage instructions.

   These details have shown that most disputes were resolved, but recurring themes around shipping reliability, communication consistency, subscription management, and care coordination have indicated areas for improvement.

2. Real User Reviews

   To evaluate real user experiences with Ivy, we analyzed feedback from Trustpilot, where the brand maintains a claimed profile. The brand holds a reported TrustScore of 4.5 out of 5, based on 3,140+ customer reviews. The overall sentiment appears to be favorable.

   Many users shared that they experienced a straightforward onboarding process, accessible communication channels, and responsive customer support. Many stated timely assistance with billing inquiries, prescription adjustments, delivery coordination, and account management.

   Users also emphasize the availability and consistency of customer service. Users report relatively fast response times via chat, email, and phone, along with effective resolution of issues such as shipment delays, billing discrepancies, or scheduling concerns related to prescription fulfillment.

   Operational conveniences, such as direct-to-home delivery, appropriate temperature-controlled packaging when required, and the ability to communicate with medical professionals for follow-up questions, were also cited as practical benefits.

   However, a few users mentioned delays during initial fulfillment and confusion around pricing structures for multi-month plans. A smaller number of users report uncertainty during dosage transitions or waiting periods associated with pharmacy processing, though several reviews indicate these issues were addressed after contacting support.

Frequently Asked Questions

1. Do insurance plans usually cover telehealth prescriptions through Ivy Rx?
   The platform does not accept insurance and operates as a cash-pay telehealth service. It highlights no insurance billing. The GLP-1 plans may be HSA/FSA-eligible, but coverage depends on your plans and compounded formulation rules.
2. Is it possible to transfer Ivy Rx prescriptions to local pharmacies?
   No. The platform does not support transferring prescriptions to local retail pharmacies. It fulfills prescriptions only through specific partner compounding pharmacies. The sole limited exception is that, for side-effect management (e.g., nausea meds), you can ask your Ivy provider to send those specific low-cost options to a local pharmacy, but core options such as GLP-1 or longevity care options must be filled and shipped via the partner pharmacy network.
3. Can Ivy RX be used alongside a primary care provider?
   Yes. The platform may work alongside your regular doctor, but it does not connect directly with them. It handles GLP-1 and longevity plans on its own, encourages you to tell your primary care provider, and leaves record-sharing and coordination up to you.

Final Words

Ivy Rx functions as a direct-to-consumer telehealth platform focused on accelerating access to prescription options through an asynchronous, intake-driven model. Care initiation relies on self-reported medical information reviewed by a provider without routine live consultation, and services are offered exclusively on a cash-pay basis, without insurance billing, prior authorization support, or reimbursement assistance.

The platform’s lower monthly pricing for GLP-1 is driven by the use of compounded formulations rather than negotiated manufacturer pricing or insurance-based cost optimization. This approach introduces material clinical and operational limitations.

The brand does not require baseline laboratory evaluation before initiating the GLP-1 plan, and eligibility determinations are primarily based on your disclosure and provider judgment rather than objective diagnostic data.

Ivy dispenses compounded options that the U.S. Food and Drug Administration does not approve. While partner pharmacies report compliance with applicable sterile compounding and outsourcing standards, these safeguards address handling and sterility rather than ensuring bioequivalence, consistent potency, or formulation uniformity.

Such variability may influence dosing accuracy, tolerability, and clinical response. Additional offerings marketed for longevity purposes are supported by limited clinical evidence rather than robust, large-scale trials.

The platform operates primarily as a medication access channel rather than a comprehensive clinical care system, and its pricing and convenience advantages must be weighed against limited medical integration, operational variability, and the inherent constraints of compounded formulations.